Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation : A longitudinal and a case-control study
Copyright © 2024 Elsevier Inc. All rights reserved..
BACKGROUND: Bariatric surgery has long-term beneficial effects on body weight and metabolic status, but there is an apparent lack of comprehensive cardiometabolic, renal, liver, and metabolomic/lipidomic panels, whereas the underlying mechanisms driving the observed postoperative ameliorations are still poorly investigated. We aimed to study the long-term effects of bariatric surgery on metabolic profile, cardiorenal and liver outcomes in association with underlying postoperative gut hormone adaptations.
METHODS: 28 individuals who underwent bariatric surgery [17 sleeve gastrectomy (SG), 11 Roux-en-Y gastric bypass (RYGB)] were followed up 3, 6 and 12 and at 10 years following surgery. Participants at 10 years were cross-sectionally compared with an age-, sex- and adiposity-matched group of non-operated individuals (n = 9) and an age-matched pilot group of normal-weight individuals (n = 4).
RESULTS: There were durable effects of surgery on body weight and composition, with an increase of lean mass percentage persisting despite some weight regain 10 years postoperatively. The improvements in metabolic and lipoprotein profiles, cardiometabolic risk markers, echocardiographic and cardiorenal outcomes persisted over the ten-year observation period. The robust improvements in insulin resistance, adipokines, activin/follistatin components and postprandial gastrointestinal peptide levels persisted 10 years postoperatively. These effects were largely independent of surgery type, except for a lasting reduction of ghrelin in the SG subgroup, and more pronounced increases in proglucagon products, mainly glicentin and oxyntomodulin, and in the cardiovascular risk marker Trimethylamine-N-oxide (TMAO) within the RYGB subgroup. Despite similar demographic and clinical features, participants 10 years after surgery showed a more favorable metabolic profile compared with the control group, in conjunction with a dramatic increase of postprandial proglucagon product secretion.
CONCLUSIONS: We demonstrate that cardiorenal and metabolic benefits of bariatric surgery remain robust and largely unchanged ten years postoperatively and are associated with durable effects on gastrointestinal- muscle- and adipose tissue-secreted hormones.
TRIAL REGISTRATION: ClinicalTrials.gov: NCT04170010.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
|---|---|
| Enthalten in: |
Metabolism: clinical and experimental - 152(2024) vom: 02. Feb., Seite 155773 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kokkinos, Alexander [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
55963-74-1 |
|---|
| Anmerkungen: |
Date Completed 07.02.2024 Date Revised 18.02.2024 published: Print-Electronic ClinicalTrials.gov: NCT04170010 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.metabol.2023.155773 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366724932 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366724932 | ||
| 003 | DE-627 | ||
| 005 | 20240218231923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.metabol.2023.155773 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1298.xml |
| 035 | |a (DE-627)NLM366724932 | ||
| 035 | |a (NLM)38181882 | ||
| 035 | |a (PII)S0026-0495(23)00377-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kokkinos, Alexander |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation |b A longitudinal and a case-control study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.02.2024 | ||
| 500 | |a Date Revised 18.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT04170010 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Bariatric surgery has long-term beneficial effects on body weight and metabolic status, but there is an apparent lack of comprehensive cardiometabolic, renal, liver, and metabolomic/lipidomic panels, whereas the underlying mechanisms driving the observed postoperative ameliorations are still poorly investigated. We aimed to study the long-term effects of bariatric surgery on metabolic profile, cardiorenal and liver outcomes in association with underlying postoperative gut hormone adaptations | ||
| 520 | |a METHODS: 28 individuals who underwent bariatric surgery [17 sleeve gastrectomy (SG), 11 Roux-en-Y gastric bypass (RYGB)] were followed up 3, 6 and 12 and at 10 years following surgery. Participants at 10 years were cross-sectionally compared with an age-, sex- and adiposity-matched group of non-operated individuals (n = 9) and an age-matched pilot group of normal-weight individuals (n = 4) | ||
| 520 | |a RESULTS: There were durable effects of surgery on body weight and composition, with an increase of lean mass percentage persisting despite some weight regain 10 years postoperatively. The improvements in metabolic and lipoprotein profiles, cardiometabolic risk markers, echocardiographic and cardiorenal outcomes persisted over the ten-year observation period. The robust improvements in insulin resistance, adipokines, activin/follistatin components and postprandial gastrointestinal peptide levels persisted 10 years postoperatively. These effects were largely independent of surgery type, except for a lasting reduction of ghrelin in the SG subgroup, and more pronounced increases in proglucagon products, mainly glicentin and oxyntomodulin, and in the cardiovascular risk marker Trimethylamine-N-oxide (TMAO) within the RYGB subgroup. Despite similar demographic and clinical features, participants 10 years after surgery showed a more favorable metabolic profile compared with the control group, in conjunction with a dramatic increase of postprandial proglucagon product secretion | ||
| 520 | |a CONCLUSIONS: We demonstrate that cardiorenal and metabolic benefits of bariatric surgery remain robust and largely unchanged ten years postoperatively and are associated with durable effects on gastrointestinal- muscle- and adipose tissue-secreted hormones | ||
| 520 | |a TRIAL REGISTRATION: ClinicalTrials.gov: NCT04170010 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Bariatric surgery | |
| 650 | 4 | |a Gut hormones | |
| 650 | 4 | |a Obesity | |
| 650 | 4 | |a Proglucagon-derived peptides | |
| 650 | 7 | |a Proglucagon |2 NLM | |
| 650 | 7 | |a 55963-74-1 |2 NLM | |
| 650 | 7 | |a Gastrointestinal Hormones |2 NLM | |
| 700 | 1 | |a Tsilingiris, Dimitrios |e verfasserin |4 aut | |
| 700 | 1 | |a Simati, Stamatia |e verfasserin |4 aut | |
| 700 | 1 | |a Stefanakis, Konstantinos |e verfasserin |4 aut | |
| 700 | 1 | |a Angelidi, Angeliki M |e verfasserin |4 aut | |
| 700 | 1 | |a Tentolouris, Nikolaos |e verfasserin |4 aut | |
| 700 | 1 | |a Anastasiou, Ioanna A |e verfasserin |4 aut | |
| 700 | 1 | |a Connelly, Margery A |e verfasserin |4 aut | |
| 700 | 1 | |a Alexandrou, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Mantzoros, Christos S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Metabolism: clinical and experimental |d 1952 |g 152(2024) vom: 02. Feb., Seite 155773 |w (DE-627)NLM000020761 |x 1532-8600 |7 nnns |
| 773 | 1 | 8 | |g volume:152 |g year:2024 |g day:02 |g month:02 |g pages:155773 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.metabol.2023.155773 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 152 |j 2024 |b 02 |c 02 |h 155773 | ||